Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

The optimum number of treatment courses for younger patients with acute myeloid leukemia (AML) is uncertain. The United Kingdom National Cancer Research Institute AML17 trial randomly assigned patients who were not high risk to a total of three versus four courses. PATIENTS AND METHODS: Patients rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnett, Alan K., Russell, Nigel H., Hills, Robert K., Knapper, Stephen, Freeman, Sylvie, Huntly, Brian, Clark, Richard E., Thomas, Ian F., Kjeldsen, Lars, McMullin, Mary Frances, Drummond, Mark, Kell, Jonathan, Spearing, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177881/
https://www.ncbi.nlm.nih.gov/pubmed/33356418
http://dx.doi.org/10.1200/JCO.20.01170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177881/
https://www.ncbi.nlm.nih.gov/pubmed/33356418
http://dx.doi.org/10.1200/JCO.20.01170

Ejemplares similares